Literature DB >> 31262415

Emergency Department Management of Acute Kidney Injury, Electrolyte Abnormalities, and Renal Replacement Therapy in the Critically Ill.

Ivan Co1, Kyle Gunnerson2.   

Abstract

Acute kidney injury (AKI) is a common sequela of critical illness. Clinical manifestation of AKI varies and can include electrolyte abnormalities, anion gap, or non-anion-gap metabolic acidosis. Treatment strategies require careful identification of the cause of the AKI, relying on both clinical history and laboratory data. Once the cause has been identified, treatment can then target the underlying cause and avoid further insults. Conservative management should first be attempted for patients with AKI. If conservative management fails, renal replacement therapy or hemodialysis can be used.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Acidosis; Acute kidney injury; Acute renal failure; Electrolyte derangement

Mesh:

Substances:

Year:  2019        PMID: 31262415     DOI: 10.1016/j.emc.2019.04.006

Source DB:  PubMed          Journal:  Emerg Med Clin North Am        ISSN: 0733-8627            Impact factor:   2.264


  3 in total

1.  Abnormal magnesium levels and their impact on death and acute kidney injury in critically ill children.

Authors:  Hikaru Morooka; Akihito Tanaka; Daisuke Kasugai; Masayuki Ozaki; Atsushi Numaguchi; Shoichi Maruyama
Journal:  Pediatr Nephrol       Date:  2021-10-26       Impact factor: 3.714

2.  Anion Gap Was Associated with Inhospital Mortality and Adverse Clinical Outcomes of Coronary Care Unit Patients.

Authors:  Tienan Sun; Chenghui Cai; Hua Shen; Jiaqi Yang; Qianyun Guo; Jingrui Zhang; Biyang Zhang; Yaodong Ding; Yujie Zhou
Journal:  Biomed Res Int       Date:  2020-08-27       Impact factor: 3.411

3.  The Relationship Between the Serum Anion Gap and All-Cause Mortality in Acute Pancreatitis: An Analysis of the MIMIC-III Database.

Authors:  Fang Gong; Quan Zhou; Chunmei Gui; Shaohua Huang; Zuoan Qin
Journal:  Int J Gen Med       Date:  2021-02-19
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.